PET/CT offers excellent accuracy in the staging of high-risk prostate cancer (PCa), yet outcomes-based evidence of the clinical benefit remains limited. We aimed to determine whether the rates of ...
Epigenomic profiling of circulating chromatin for early detection and monitoring of neuroendocrine prostate cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Genitourinary Cancers Symposium.
Men diagnosed at screening aged 50 years projected to have 16% chance that cancer would not have been detected within 15 years.
PHOENIX — Prostate cancer is one of the most common cancers in the world. While many prostate cancers grow slowly and remain localized, other types are aggressive and spread quickly. That's why Dr.
Timing and uptake of germline testing in patients with somatic BRCA1/2 pathogenic or likely pathogenic variants in solid tumors: A real-world study from community oncology practices. Identifying ...
Over the past decade, millions of men without symptoms of prostate cancer have voluntarily undergone a prostate-specific ...
Advanced age raises mortality risk in metastatic prostate cancer. Learn how PSA, tumour grade, and treatment influence ...
One Memphis man says his world stopped when he was diagnosed with prostate cancer—also known as the silent killer—back in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results